{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:26:36Z","timestamp":1788315996235,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1124\/dmd.111.039529","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T03:14:39Z","timestamp":1306466079000},"page":"1768-1776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["In Vitro Metabolism of the Mycotoxin Enniatin B in Different Species and Cytochrome P450 Enzyme Phenotyping by Chemical Inhibitors"],"prefix":"10.1016","volume":"39","author":[{"given":"Christiane K.","family":"F\u00e6ste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.111.039529_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01103344","article-title":"Production of type A trichothecenes and enniatin B Fusarium sambucinum Fuckel sensu lato","volume":"129","author":"Altomare","year":"1995","journal-title":"Mycopathologia"},{"key":"10.1124\/dmd.111.039529_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2133\/dmpk.25.93","article-title":"Species differences in mechanism-based inactivation of CYP3A in humans, rats and mice","volume":"25","author":"Aueviriyavit","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.111.039529_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.111.039529_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mnfr.200800183","article-title":"The Fusarium toxin enniatin B exerts no genotoxic activity, but pronounced cytotoxicity in vitro","volume":"53","author":"Behm","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1124\/dmd.111.039529_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1139\/v92-165","article-title":"Isolation and characterization of enniatins from fusarium-avenaceum Daom-196490","volume":"70","author":"Blais","year":"1992","journal-title":"Canadian J Chem"},{"key":"10.1124\/dmd.111.039529_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/00498250010021684","article-title":"Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man","volume":"30","author":"Bogaards","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.111.039529_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00436056","article-title":"Toxicity and toxin production by Fusarium isolates from New Zealand","volume":"108","author":"Bosch","year":"1989","journal-title":"Mycopathologia"},{"key":"10.1124\/dmd.111.039529_bib8","first-page":"1130","article-title":"In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse","volume":"25","author":"Chauret","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.039529_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/dmd.106.014027","article-title":"The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools","volume":"35","author":"De Buck","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.039529_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.1998.00679.x","article-title":"Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes","volume":"45","author":"Eagling","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.111.039529_bib11","first-page":"563","article-title":"Biosynthesis and biological activity of enniatins","volume":"62","author":"Fir\u00e1kov\u00e1","year":"2007","journal-title":"Pharmazie"},{"key":"10.1124\/dmd.111.039529_bib12","first-page":"289","article-title":"[Zur Gewinnung von enniatinen aus dem myzel verschiedener fusarien]","volume":"16","author":"G\u00e4umann","year":"1950","journal-title":"Phytopathol Z"},{"key":"10.1124\/dmd.111.039529_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/tx0002583","article-title":"Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity","volume":"14","author":"Guengerich","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.111.039529_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11095-004-9015-1","article-title":"Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches","volume":"22","author":"Ito","year":"2005","journal-title":"Pharmaceut Res"},{"key":"10.1124\/dmd.111.039529_bib15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.toxicon.2006.02.012","article-title":"Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum","volume":"47","author":"Ivanova","year":"2006","journal-title":"Toxicon"},{"key":"10.1124\/dmd.111.039529_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3920\/WMJ2010.1225","article-title":"Enniatin B1 is a substrate of intestinal P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein","volume":"3","author":"Ivanova","year":"2010","journal-title":"World Mycotoxin J"},{"key":"10.1124\/dmd.111.039529_bib17","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1007\/s00216-011-4964-9","article-title":"In vitro phase I metabolism of the depsipeptide enniatin B","volume":"400","author":"Ivanova","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.111.039529_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(96)00184-2","article-title":"Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data","volume":"73","author":"Iwatsubo","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.111.039529_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10408390601062021","article-title":"Emerging fusarium-mycotoxins fusaprofilin, beauvericin, enniatins, and moniliformin: a review","volume":"48","author":"Jestoi","year":"2008","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1124\/dmd.111.039529_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/mnfr.200400026","article-title":"Levels of mycotoxins and sample cytotoxicity of selected organic and conventional grain-based products purchased from Finnish and Italian markets","volume":"48","author":"Jestoi","year":"2004","journal-title":"Mol Nutr Food Res"},{"key":"10.1124\/dmd.111.039529_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.foodchem.2008.12.105","article-title":"Determination of Fusarium mycotoxins beauvericin and enniatins (A, A1, B, B1) in eggs of laying hens using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"115","author":"Jestoi","year":"2009","journal-title":"Food Chem"},{"key":"10.1124\/dmd.111.039529_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1185\/030079902125000552","article-title":"Efficacy and acceptability of fusafungine, a local treatment for both nose and throat infections, in adult patients with upper respiratory tract infections","volume":"18","author":"Krosl\u00e1k","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/dmd.111.039529_bib23","series-title":"Analytische, Pharmakologische und Mikrobiologische Untersuchungen des Ionophoren Antibiotikums Fusafungin","author":"Lohmann","year":"1988"},{"key":"10.1124\/dmd.111.039529_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.foodchem.2010.06.058","article-title":"Further data on the levels of emerging Fusarium mycotoxins enniatins (A, A1, B, B1), beauvericin and fusaproliferin in breakfast and infant cereals from Morocco","volume":"124","author":"Mahnine","year":"2011","journal-title":"Food Chem"},{"key":"10.1124\/dmd.111.039529_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.111.039529_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/np970031g","article-title":"Isolation and characterization of new anti-HIV and cytotoxic leads from plants, marine, and microbial organisms","volume":"60","author":"McKee","year":"1997","journal-title":"J Nat Prod"},{"key":"10.1124\/dmd.111.039529_bib27","first-page":"1316","article-title":"Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans","volume":"29","author":"Naritomi","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.039529_bib28","first-page":"49","article-title":"Determination of enniatins in cereal products from the Swiss market","volume":"61","author":"Noser","year":"2007","journal-title":"Lebensmittelchemie"},{"key":"10.1124\/dmd.111.039529_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data","volume":"283","author":"Obach","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.111.039529_bib30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/dmd.30.7.831","article-title":"Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach","volume":"30","author":"Obach","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.039529_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.111.039529_bib32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.foodcont.2011.02.015","article-title":"Determination of Fusarium mycotoxins enniatins, beauvericin and fusaproliferin in cereals and derived products from Tunisia","volume":"22","author":"Queslati","year":"2011","journal-title":"Food Control"},{"key":"10.1124\/dmd.111.039529_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bcp.2008.07.003","article-title":"In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes","volume":"76","author":"Quintieri","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.111.039529_bib34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.111.039529_bib35","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/00498250802491662","article-title":"Determination of microsome and hepatocyte scaling factors for in vitro\/in vivo extrapolation in the rat and dog","volume":"38","author":"Smith","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.111.039529_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/tx800415j","article-title":"Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment","volume":"22","author":"Smith","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.111.039529_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3920\/WMJ2010.1245","article-title":"Beauvericin and enniatin: emerging toxins and\/or remedies?","volume":"3","author":"Tedjiotsop Feudijo","year":"2010","journal-title":"World Mycotoxin J"},{"key":"10.1124\/dmd.111.039529_bib38","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1010994022294","article-title":"Optimizing drug development: strategies to assess drug metabolism\/transporter interaction potential \u2013 toward a consensus","volume":"18","author":"Tucker","year":"2001","journal-title":"Pharmaceut Res"},{"key":"10.1124\/dmd.111.039529_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijfoodmicro.2007.07.021","article-title":"Fusarium avenaceum \u2013 the North European situation","volume":"119","author":"Uhlig","year":"2007","journal-title":"Int J Food Microbiol"},{"key":"10.1124\/dmd.111.039529_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/138920010792927334","article-title":"Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model","volume":"11","author":"Wan","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.111.039529_bib41","first-page":"300","article-title":"Predicting drug-drug interactions: an FDA perspective","volume":"11","author":"Zhang","year":"2009","journal-title":"AASP J"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624224764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.111.039529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:00:58Z","timestamp":1739908858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624224764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0090955624224764"],"URL":"https:\/\/doi.org\/10.1124\/dmd.111.039529","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Metabolism of the Mycotoxin Enniatin B in Different Species and Cytochrome P450 Enzyme Phenotyping by Chemical Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.111.039529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}